Table 7.
Identified significant biomarker hub proteins in the continuation of the comorbidities.
| Rank | Symbol | Name | Degree | Affiliated comorbidity |
|---|---|---|---|---|
| 1 | IL1B | Interleukin 1 beta | 50 | Hypertension, diabetes, obesity, and lung cancer. |
| 2 | CXCL8 | C-X-C motif chemokine ligand 8 | 38 | Hypertension, diabetes, obesity, and lung cancer. |
| 3 | FN1 | Fibronectin 1 | 37 | Hypertension, diabetes, obesity, and lung cancer. |
| 4 | MMP9 | Matrix metallopeptidase 9 | 35 | Hypertension, diabetes, obesity, and lung cancer. |
| 5 | CXCL10 | C-X-C motif chemokine 10 | 32 | Hypertension, diabetes, obesity, and lung cancer. |
| 6 | IL1A | Interleukin 1 alpha | 21 | Hypertension, diabetes, obesity, and lung cancer. |
| 7 | IRF7 | Interferon regulatory factor 7 | 20 | Diabetes, obesity, and lung cancer. |
| 8 | VWF | Von Willebrand factor | 19 | Hypertension, diabetes, obesity, and lung cancer. |
| 8 | CXCL9 | C-X-C motif chemokine ligand 9 | 19 | Hypertension, diabetes, obesity, and lung cancer. |
| 10 | ISG15 | Interferon-stimulated gene 15 | 18 | Hypertension and lung cancer. |